Annual Meeting 2018

Our first Annual Meeting will be held on Thursday, 30 August 2018 at the Cleveland Botanical Garden from 8 a.m. to 3 p.m. Registration is free but requested for this event. To register please click the button below, fill out and submit the Google form.

Register 

The meeting is meant to be an opportunity for Cleveland Brain Health Initiative faculty to meet and discuss their work. The morning will feature five short talks, one from each member institution, that will allow us to learn about some of the neuroscience research going on at each campus. The afternoon session will include poster viewing and the inaugural Story Landis Lecture.

There are several breakout discussion groups throughout the day, and breakfast and lunch will be served. These groups and meals are meant to provide our investigators with a chance to enjoy the Garden, and an opportunity to meet each other and discuss their work.

Meeting Agenda

Scheduled Speakers

• Lin Mei, MD, PhD, Allen C. Holmes Professor and Chair, Department of Neurosciences, CWRU School of Medicine and Director, CBHI 
• Anthony Furlan, MD, Professor and Gilbert W. Humphrey Chair, Department of Neurology, UH Cleveland Medical Center
• Pamela B. Davis, MD, PhD, Dean, School of Medicine, and Senior Vice President for Medical Affairs, Case Western Reserve University
• Andrew Pieper, MD, PhD, Professor and Morley-Mather Chair in Neuropsychiatry, UH Cleveland Medical Center, Investigator, Harrington Discovery Institute, Psychiatrist, Louis Stokes Cleveland VA Medical Center
  • "Discovery of New Neuroprotective Strategies"
• Anthony Wynshaw-Boris, MD, PhD, Professor and Chair, Genetics and Genome Sciences, CWRU
  • “Modeling human neurogenetic diseases using the mouse and human induced pluripotent stem cells.”
• Martha Sajatovic, MD, Professor Psychiatry and Neurology, Willard Brown Chair in Neurological Outcomes Research, and Director Neurological and Behavioral Outcomes Center, UH Cleveland Medical Center
  • "Optimizing brain health by targeting stigma, and engaging our community."
• James Leverenz, MD, Director Cleveland Lou Ruvo Center for Brain Health, Cleveland Clinic
  • "Patient-based research in neurodegeneration"
• Jayme Knutson, PhD, Director of Research, Physical Medicine and Rehabilitation, MetroHealth and Cleveland FES Center
  • "Electrical stimulation for functional restoration in CNS paralysis and pain modulation."
• Story Landis PhD, Former Director, National Institute of Neurological Diseases and Stroke
  • "Better Together: Accelerating progress in brain sciences"

Learning Objectives

After attending this program, participants will be able to: 

• Discuss ongoing local research in Behavior, Drug Discovery, Science Policy, Alzheimer’s Disease, Neurodegeneration, and Neurorehabilitation
• Confer with local neuroscientists, physicians and physician-scientists on scientific advances for patient care.

Accreditation Statement

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

The policy of Case Western Reserve University School of Medicine CME Program (CWRU) requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests.  Disclosure will be made to activity participants prior to the commencement of the activity.  Case Western Reserve University School of Medicine CME Program also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.